A Phase 3 study of BGF MDI in COPD

Recruiting Phase 3 NCT06283966

Study Description

Evaluating the effectiveness of a triple inhaler therapy in improving cardiopulmonary outcomes in people with chronic obstructive pulmonary disease (COPD)

Study Details

Registry ID:
NCT06283966
Conditions:
COPD (Chronic Obstructive Pulmonary Disease)
Phase:
Phase 3
Target Enrollment:
5,250 participants
Start Date:
Healthy Volunteers:
No

Study Locations (639 sites)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.org.

View full study details and check eligibility →